Wendy Stock to Ikaros Transcription Factor
This is a "connection" page, showing publications Wendy Stock has written about Ikaros Transcription Factor.
Connection Strength
0.559
-
Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665. Leuk Lymphoma. 2016 10; 57(10):2298-306.
Score: 0.532
-
The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet. 2013 Mar; 45(3):242-52.
Score: 0.027